Intelligent Net Income Per Share from 2010 to 2024

INBS Stock  USD 1.48  0.04  2.63%   
Intelligent Bio Net Loss yearly trend continues to be comparatively stable with very little volatility. Net Loss will likely drop to -6.7 in 2024. From the period from 2010 to 2024, Intelligent Bio Net Loss quarterly data regression had mean square error of  32.00 and mean deviation of  5.55. View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
(6.38)
Current Value
(6.70)
Quarterly Volatility
6.6933669
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Intelligent Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Intelligent Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 158.8 K or Selling General Administrative of 4.9 M, as well as many indicators such as Price To Sales Ratio of 0.89, Dividend Yield of 0.0 or PTB Ratio of 0.37. Intelligent financial statements analysis is a perfect complement when working with Intelligent Bio Valuation or Volatility modules.
  
Check out the analysis of Intelligent Bio Correlation against competitors.

Latest Intelligent Bio's Net Income Per Share Growth Pattern

Below is the plot of the Net Income Per Share of Intelligent Bio Solutions over the last few years. It is Intelligent Bio's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Intelligent Bio's overall financial position and show how it may be relating to other accounts over time.
Net Income Per Share10 Years Trend
Slightly volatile
   Net Income Per Share   
       Timeline  

Intelligent Net Income Per Share Regression Statistics

Arithmetic Mean(6.84)
Coefficient Of Variation(97.80)
Mean Deviation5.55
Median(6.38)
Standard Deviation6.69
Sample Variance44.80
Range20.0161
R-Value(0.58)
Mean Square Error32.00
R-Squared0.34
Significance0.02
Slope(0.87)
Total Sum of Squares627.22

Intelligent Net Income Per Share History

2024 -6.7
2023 -6.38
2022 -10.58
2021 -11.33
2020 -16.22
2019 -8.92
2018 -21.01

About Intelligent Bio Financial Statements

Intelligent Bio shareholders use historical fundamental indicators, such as Net Income Per Share, to determine how well the company is positioned to perform in the future. Although Intelligent Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Intelligent Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Intelligent Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss(6.38)(6.70)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Intelligent Stock Analysis

When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.